About this trial
This study aims to investigate how different types and intensities of exercise affect muscle recovery in individuals taking statin medications compared to healthy controls. Statins are essential for cardiovascular prevention but are often associated with muscle-related side effects (SAMS), which can be exacerbated by physical activity.
The study will compare aerobic cycling (low muscular strain) with resistance training (RT) at increasing intensities (40%, 60%, and 80% of estimated 1-repetition maximum; e1RM). Researchers will measure markers of muscle damage, such as creatine kinase (CK) levels, and subjective recovery needs to determine which exercise modalities and intensities are best tolerated by statin users. The goal is to provide evidence for more individualized and safer exercise recommendations for this population.
Eligibility criteria
Qualifiers
Sedentary behavior (defined as < 1 hour of planned physical activity per week)
Low occupational physical activity
Age between 30 and 65 years
Non-smoker
Disqualifiers
BMI < 20 kg/m² or > 30 kg/m²
Smoking or smoking cessation < 1 year ago
Medical conditions or musculoskeletal issues that preclude eligibility for full physical effort or interfere with outcome measures
Medication (other than statins) that may interfere with physical exercise or outcome measures (assessment on a case-by-case basis during screening visit)
Trial design
Treatments tested in this trial
- Dose-Escalation Exercise Protocol
Treatment groups
Sponsors and collaborators
Raffaele Mazzolari
Lead sponsor
Medical University Innsbruck
Sponsor institution
Universitaet Innsbruck
Collaborator